Filing Details

Accession Number:
0001787306-24-000128
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-21 16:39:18
Reporting Period:
2024-08-19
Accepted Time:
2024-08-21 16:39:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1787306 Arcutis Biotherapeutics Inc. ARQT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741987 Patrick Burnett C/O Arcutis Biotherapeutics, Inc.
3027 Townsgate Road Suite 300
Westlake Village CA 91361
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-08-19 1,728 $8.29 194,859 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale was made pursuant to the Issuer's mandatory sell-to-cover requirements implemented to satisfy the tax withholding obligations associated with the vesting of the reporting person's Restricted Stock Units.
  2. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $8.27 to $8.30, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.